Development of antisense oligonucleotide (ASO) technology against Tgf-β signaling to prevent scarring during flexor tendon repair.
| Image |  |
|---|---|
| Description | scientific article published on June 2015 |
| Author/s |
author: Michael B Geary Hani Awad |
| Publication date | June 1, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |